Compare AstraZeneca plc (AZN) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Prologis Inc — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Prologis Inc trades at $139.1 (market cap $132.57B). The key difference: AstraZeneca plc is the larger of the two by market cap, and Prologis Inc pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| AZN | PLD | |
|---|---|---|
Market Cap | $248.14B | $132.57B |
Sector | Health | Real Estate |
52-Week High | $209.48 | $149.96 |
52-Week Low | $147.06 | $104.81 |
Enterprise Value | $275.41B | $167.31B |
Dividend Yield | 2.01% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
